Shares of Bio-Techne Corp. TECH slipped 1.32% to $67.44 Wednesday, on what proved to be an all-around rough trading session ...

Shares of Bio-Techne Corp. TECH slipped 2.25% to $68.34 Tuesday, on what proved to be an all-around positive trading session ...

Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here ...

Other economic data to watch this week include the Institute for ... Aflac, Align Technology, Allstate, Arm, AvalonBay Communities, Bio-Techne, Boston Scientific, Bunge Global, Cencora, Cognizant ...

Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance ...

Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

In the last three months, 4 analysts have published ratings on Bio-Techne (NASDAQ:TECH), offering a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market ...

Bio-Techne Co. has a 1-year low of $61.16 and a 1-year high of $85.57. The company has a current ratio of 3.94, a quick ratio of 3.26 and a debt-to-equity ratio of 0.14.

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early ...